MAPK8 and cancer: Administration of SC144, a complexed IL-6R-gp130 inhibitor, alleviated mechanical and thermal hypersensitivity in BCP rats [21, 22], reversing the upregulation of TRPA1, p-p38-MAPK, p-JNK [22], and PI3K-mTOR [21] induced by cancer.